The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized ANtibodies for GastroEsophageal Adenocarcinoma (PANGEA): Primary efficacy analysis of the phase II platform trial (NCT02213289).
 
Daniel V.T. Catenacci
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genmab; Genmab; Genmab; Genmab; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; NantWorks; NantWorks; NantWorks; NantWorks; OncoPlex Diagnostics; OncoPlex Diagnostics; OncoPlex Diagnostics; OncoPlex Diagnostics; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech; Genentech; Genentech; Genentech; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Merck; Merck; Merck; Merck
 
Samantha Lomnicki
No Relationships to Disclose
 
Leah Chase
No Relationships to Disclose
 
Bryan Peterson
No Relationships to Disclose
 
Kelly Moore
No Relationships to Disclose
 
Ugne Markevicius
No Relationships to Disclose
 
Lindsay Alpert
No Relationships to Disclose
 
Namrata Setia
No Relationships to Disclose
 
John Hart
No Relationships to Disclose
 
Chih-Yi Liao
No Relationships to Disclose
 
Uzma Siddiqui
No Relationships to Disclose
 
Kiran Turaga
No Relationships to Disclose
 
Mitchell C. Posner
Consulting or Advisory Role - Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
 
Kristen Kipping-Johnson
No Relationships to Disclose
 
Sunil Narula
No Relationships to Disclose
 
Murtuza M. Rampurwala
Stock and Other Ownership Interests - Glaxosmithkline; Glaxosmithkline; Glaxosmithkline; Glaxosmithkline
Honoraria - Medscape; Medscape; Medscape; Medscape
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Heron; Heron; Heron; Heron; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology
Travel, Accommodations, Expenses - Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Dava Oncology; Dava Oncology; Dava Oncology; Dava Oncology; Merck; Merck; Merck; Merck
 
Yuan Ji
Stock and Other Ownership Interests - Laiya Consulting; Laiya Consulting; Laiya Consulting; Laiya Consulting; Laiya Consulting (I); Laiya Consulting (I); Laiya Consulting (I); Laiya Consulting (I)
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma
 
Theodore Karrison
No Relationships to Disclose
 
Blase N. Polite
Honoraria - American Journal of Managed Care; American Journal of Managed Care; American Journal of Managed Care; American Journal of Managed Care; HMP; HMP; HMP; HMP; Physicans' Education Resource; Physicans' Education Resource; Physicans' Education Resource; Physicans' Education Resource; Simon-Kucher and Partners; Simon-Kucher and Partners; Simon-Kucher and Partners; Simon-Kucher and Partners
Consulting or Advisory Role - Cancer Expert Now; Cancer Expert Now; Cancer Expert Now; Cancer Expert Now
Research Funding - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Tapestry Pharmaceuticals; Tapestry Pharmaceuticals; Tapestry Pharmaceuticals; Tapestry Pharmaceuticals
 
Hedy L. Kindler
Consulting or Advisory Role - Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; ipsen; ipsen; ipsen; ipsen; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Merck; Merck; Merck; Merck; Paradox Therapeutics; Paradox Therapeutics; Paradox Therapeutics; Paradox Therapeutics
Research Funding - Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Inhibrx (Inst); Inhibrx (Inst); Inhibrx (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst)